DHL Recognized for Excellence with Logistics and Supply Chain Award at IMAPAC ABEA 2026

18 March 2026 5 min read

DHL won the Best Logistics & Supply Chain Management Supplier Award under the Asia’s 3PL Excellence category, at IMAPAC Asia-Pacific Biopharma Excellence Awards (ABEA) 2026.¹

The ABEA spotlights exceptional achievements in the Asian biopharma sector, giving recognition to the contributions of industry leaders and trendsetters who help inspire innovation for the future of biopharma.² This marks a milestone for DHL’s continued efforts and leadership in the region’s healthcare and biopharma industry.

To qualify for nomination, companies must be involved in biologics development or manufacturing, have a strong presence in the APAC region, and demonstrate notable progress in recent years. After reviewing all submissions, the top 5–7 companies in each category are shortlisted. Winners are then determined through 100% voting results from the Biologics community, with the highest‑voted company in each category receiving the award.

This win also came at a pivotal time, when the Asia Pacific (APAC) healthcare cold chain market is projected to see rapid growth, reaching USD 42.5 billion (about €37.1billion) by 2031.³ This surge in healthcare cold chain demand has made logistics excellence not just a vision for the future, but the baseline requirement of the present.

DHL's efforts in health logistics

DHL, as a strategic hub in the region’s network, strives for logistics excellence through our long-standing commitment to delivering trusted, world-class supply chain solutions across Asia. DHL Group has also invested €500 million into APAC’s Life Sciences and Healthcare (LSHC) infrastructure across all units. Part of this investment went into launching a new €10 million Pharma Hub in Singapore last year, fitted with 8,200 m² of GDP/Good Manufacturing Practice (GMP)‑compliant space with ambient (15 - 25°C) and cold‑room (2 - 8°C) zones. Its strategic linkage to Changi Airport and Tuas Mega Port helps to serve regional and global distribution needs for pharmaceutical logistics.⁴

DHL’s focus on constant innovation, coupled with key investments and strategic infrastructure has reinforced its role as a key player in the APAC LSHC logistics and supply chain management ecosystem. This achievement at ABEA 2026 stands as a testament to our ability to support industry needs and deliver excellence.

To learn more about DHL Health Logistics, visit Life Sciences & Healthcare Logistics - DHL.